By KEN TERRY

Back in 2015, 20 major health systems and payers pledged to
convert 75% of their business to value-based arrangements by 2020. Today, more than
two-thirds of payments from U.S. commercial health insurers are tied to some
kind of value-based model. By 2021, the health plans expect three-quarters of their
payments will be value-based.

However, a recent analysis of Change Healthcare data by Modern
Healthcare found that the percentage of value-based revenue tied up in
upside/downside risk contracts was in the single digits. Among the types of two-sided
risk contracts that provider organizations had were capitation or global
payment (7.3%), pay for performance (6.5%), prospective bundled payment (5%),
population-based payment (5.8%), and retrospective bundled payment (4.1%).

An AMGA survey picked up signs of a recession in risk contracting
in 2016. A year earlier, survey respondents—mostly large groups–had predicted
their organizations would get 9 percent of revenue from capitated products. In
2016, the actual figure was 5 percent, according to a Health Affairs
post by the AMGA’s Chet Speed and the late Donald Fisher.

The authors
cited a number of obstacles to the spread of risk contracting, including
“limited commercial value-based or risk-based products in their local markets; the
inability to access administrative claims data from all payers; the massive
administrative burden of submitting data in different formats to different
payers; lack of access to investment capital; and inadequate infrastructure.”

Fast forward a
few years, and most of the same ingredients for risk-contract aversion remain.
In researching my new book in progress, for example, I discovered that ACOs
were having a hard time getting claims data from commercial payers. That made
it more difficult for them to manage population health and to measure physician
performance, which is critical to improvement and to the selection of
high-value specialists. The insurers apparently did not want to reveal what
they were paying providers, despite the value of ACOs to their bottom line.

Even if plans are willing to meet providers halfway, they still
find

View Entire Article on TheHealthCareBlog.com